Home > Publications database > A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer Pain. |
Journal Article | DKFZ-2017-03531 |
; ; ; ; ; ; ; ; ; ; ; ;
2015
Cell Press
Cambridge, Mass.
This record in other databases:
Please use a persistent id in citations: doi:10.1016/j.ccell.2015.04.017
Abstract: Cancer pain is a debilitating disorder and a primary determinant of the poor quality of life. Here, we report a non-vascular role for ligands of the Vascular Endothelial Growth Factor (VEGF) family in cancer pain. Tumor-derived VEGF-A, PLGF-2, and VEGF-B augment pain sensitivity through selective activation of VEGF receptor 1 (VEGFR1) expressed in sensory neurons in human cancer and mouse models. Sensory-neuron-specific genetic deletion/silencing or local or systemic blockade of VEGFR1 prevented tumor-induced nerve remodeling and attenuated cancer pain in diverse mouse models in vivo. These findings identify a therapeutic potential for VEGFR1-modifying drugs in cancer pain and suggest a palliative effect for VEGF/VEGFR1-targeting anti-angiogenic tumor therapies.
Keyword(s): Angiogenesis Inhibitors ; Vascular Endothelial Growth Factor Receptor-1
![]() |
The record appears in these collections: |